% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Schunn:285359,
author = {F. A. Schunn and R. A. El Shafie and D. Kronsteiner and L.
D. Sauer and A. Kudak and N. Bougatf and D. Oetzel and A.
Krämer and S. Regnery and T. Machmer and J. Debus$^*$ and
N. H. Nicolay$^*$},
title = {{O}ncologic treatment support via a dedicated mobile app: a
prospective feasibility evaluation ({OPTIMISE}-1).},
journal = {Strahlentherapie und Onkologie},
volume = {200},
number = {6},
issn = {0179-7158},
address = {Heidelberg},
publisher = {Springer Medizin},
reportid = {DKFZ-2023-02328},
pages = {475-486},
year = {2024},
note = {2024 Jun;200(6):475-486 / #LA:E055#},
abstract = {Mobile health (mhealth) is gaining interest, with mobile
devices and apps being ever more available among medical
facilities and patients. However, in the field of radiation
oncology, the medical benefits of mhealth apps are still
underexplored. As an additional approach to patient care
during radiotherapy, we designed a mobile treatment
surveillance app based on patient-reported outcomes.We aimed
to examine the feasibility of app-based treatment
surveillance in patients undergoing radiotherapy (RT).
Alongside technical practicability and acceptance, we
assessed patient satisfaction and quality of life during
treatment.This prospective single-center study was performed
at Heidelberg University Hospital between August 2018 and
January 2020. During RT we measured patients' quality of
life, symptoms, and treatment satisfaction. Respective
questionnaires (EORTC QLQ-C30 with diagnosis-specific
modules, RAND PSQ-18) were presented to patients via a
mobile app running on a designated tablet device. The
primary endpoint was determined by the fraction of patients
who completed at least $80\%$ of the items. Secondary
endpoints were disease-related quality of life and patient
satisfaction.A total of 49 cancer patients (14 breast, 13
pelvic, 12 lung, 10 prostate) were eligible for analysis.
$79.6\%$ $(95\%$ confidence interval: $66.4-88.5\%;$ n = 39)
of all patients completed at least $80\%$ of the items
received by the mobile app. A mean of 227.5 ± 48.25
questions were answered per patient. Breast cancer patients
showed the highest rate of answered questions, with $92.9\%$
(n = 13) completing at least $80\%$ of the items.Patients
showed high acceptance, with $79.6\%$ (n = 39) completing at
least $80\%$ of the given items. The use of a mobile app for
reporting symptoms and quality of life during RT is feasible
and well accepted by patients. It may allow for
resource-efficient, detailed feedback to the medical staff
and assist in the assessment of side effects over time.},
keywords = {Cancer (Other) / Patient-reported outcome measures (Other)
/ Quality of life (Other) / Radiotherapy (Other) / mhealth
(Other)},
cin = {E050 / FR01 / E055},
ddc = {610},
cid = {I:(DE-He78)E050-20160331 / I:(DE-He78)FR01-20160331 /
I:(DE-He78)E055-20160331},
pnm = {315 - Bildgebung und Radioonkologie (POF4-315)},
pid = {G:(DE-HGF)POF4-315},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:37947806},
doi = {10.1007/s00066-023-02166-7},
url = {https://inrepo02.dkfz.de/record/285359},
}